MedTrace Logo

Plasma Biomarkers in Cardiac Valve Surgery

NCT02641665 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2017-10-06

No results posted yet for this study

Summary

The level of four biomarkers will be measured in the patients' plasma after induction of anaesthesia. There biomarkers are NT-ProBNP, ST2, Galectin-3 and GDF-15. The level of these marker will then be correlated with early (30 days) and late (one year) patients' prognosis and with functional recovery (MLHFQ score).

Conditions

  • Elective Valvular Cardiac Surgery

Interventions

PROCEDURE

Cardiac valve surgery

Aortic or mitral valve replacement/repair performed in isolation of in addition to coronary artery bypass graft(s).

Sponsors & Collaborators

  • University of Liege

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-12-31
Completion
2018-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02641665 on ClinicalTrials.gov